The results hoists two compounds, (Z)-9,17-octadecadienal and n-hexadecanoic acid as potential lead molecules for developing novel selective MAO-A inhibitors which can confer herbal remedy in the treatment of psychiatric disorders such as depression, anxiety, and also cognitive impairments in Alzheimer’s and Parkinson’s Diseases. This evidence concerns the gene MAOA and Parkinson disease.